These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 169287
1. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components. Megyesi K, Kahn CR, Roth J, Gorden P. J Clin Endocrinol Metab; 1975 Sep; 41(3):475-84. PubMed ID: 169287 [Abstract] [Full Text] [Related]
2. Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major. Werther GA, Matthews RN, Burger HG, Herington AC. J Clin Endocrinol Metab; 1981 Oct; 53(4):806-9. PubMed ID: 7026588 [Abstract] [Full Text] [Related]
3. Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs. Schlumpf U, Heimann R, Zapf J, Froesch ER. Acta Endocrinol (Copenh); 1976 Jan; 81(1):28-42. PubMed ID: 946140 [Abstract] [Full Text] [Related]
4. Changes in NSILA-S in response to somatotropin administration and hypophysectomy. Franklin RC, Rennie GC, Burger HG, Cameron DP. J Clin Endocrinol Metab; 1978 Jul; 47(1):91-6. PubMed ID: 263296 [Abstract] [Full Text] [Related]
5. Hypoglycemia in association with extrapancreatic tumors: demonstration of elevated plasma NSILA-s by a new radioreceptor assay. Megyesi K, Kahn CR, Roth J, Gorden P. J Clin Endocrinol Metab; 1974 May; 38(5):931-4. PubMed ID: 4823931 [No Abstract] [Full Text] [Related]
6. Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? Widmer U, Zapf J, Froesch ER. J Clin Endocrinol Metab; 1982 Nov; 55(5):833-9. PubMed ID: 6749876 [Abstract] [Full Text] [Related]
7. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin. Franklin RC, Rennie GC, Burger HG, Cameron DP. J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319 [Abstract] [Full Text] [Related]
8. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy. Eigenmann JE, Becker M, Kammermann B, Leemann W, Heimann R, Zapf J, Froesch ER. Acta Endocrinol (Copenh); 1977 Aug; 85(4):818-22. PubMed ID: 578061 [Abstract] [Full Text] [Related]
9. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. Kaufmann U, Zapf J, Torretti B, Froesch ER. J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254 [Abstract] [Full Text] [Related]
10. Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs. Eigenmann JE, Francke-Mäder M, Zapf J, Froesch ER. Acta Endocrinol (Copenh); 1977 Jul; 85(3):571-8. PubMed ID: 577341 [Abstract] [Full Text] [Related]
11. The NSILA-s receptor in liver plasma membranes. Characterization and comparison with the insulin receptor. Megyesi K, Kahn CR, Roth J, Neville DM, Nissley SP, Humbel RE, Froesch ER. J Biol Chem; 1975 Dec 10; 250(23):8990-6. PubMed ID: 391 [Abstract] [Full Text] [Related]
12. Radioimmunoassay for insulin-like growth factor II (IGF-II). Asakawa K, Hizuka N, Takano K, Fukuda I, Sukegawa I, Demura H, Shizume K. Endocrinol Jpn; 1990 Oct 10; 37(5):607-14. PubMed ID: 2086202 [Abstract] [Full Text] [Related]
13. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. Zapf J, Schoenle E, Jagars G, Sand I, Grunwald J, Froesch ER. J Clin Invest; 1979 May 10; 63(5):1077-84. PubMed ID: 447829 [Abstract] [Full Text] [Related]
14. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa. Sizonenko PC, Rabinovitch A, Schneider P, Paunier L, Wollheim CB, Zahnd G. Pediatr Res; 1975 Sep 10; 9(9):733-8. PubMed ID: 1105371 [Abstract] [Full Text] [Related]
15. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. Daughaday WH, Trivedi B, Kapadia M. J Clin Endocrinol Metab; 1981 Aug 10; 53(2):289-94. PubMed ID: 7019228 [Abstract] [Full Text] [Related]
16. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Rinderknecht E, Humbel RE. Proc Natl Acad Sci U S A; 1976 Jul 10; 73(7):2365-9. PubMed ID: 1065887 [Abstract] [Full Text] [Related]
17. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation. Kahn CR, Megyesi K, Roth J. J Clin Invest; 1976 Feb 10; 57(2):526-9. PubMed ID: 1254732 [Abstract] [Full Text] [Related]
18. Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S). Franklin RC, Rennie GC, Burger HG, Cameron DP. Clin Endocrinol (Oxf); 1980 Feb 10; 12(2):127-36. PubMed ID: 6772355 [Abstract] [Full Text] [Related]
19. The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation. Eigenmann JE, Becker M, Kammermann B, Zapf J, Leemann W, Froesch ER. Acta Endocrinol (Copenh); 1977 Nov 10; 86(3):498-503. PubMed ID: 579020 [Abstract] [Full Text] [Related]
20. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats. Franklin RC, Rennie GC, Cameron DP. J Endocrinol; 1979 Jun 10; 81(3):331-7. PubMed ID: 469463 [Abstract] [Full Text] [Related] Page: [Next] [New Search]